1. Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board

    forbes.com BoardMoves
    Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board

    Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...

    Read Full Article

    Login to comment.

    Related Articles

  1. Search:

  2. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content

  3. Quotes

    1. We welcome Bill to the Zoetis Board.
    2. He brings significant expertise and relevant industry and operational experience to Zoetis and I am confident he will provide valuable insight and perspectives as we continue to enhance our position as the world leader in animal health.
    3. As the industry leader in the animal health market, Zoetis is an exceptional company with a diverse product portfolio and great long-term value creation potential.

  4. Topics Mentioned

  5. Authors